Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA ® 800 mg ( " Jonson & Jonson " , Russia)
Condition: Bioequivalence Interventions: Drug: GP30101; Drug: Prezista® Sponsor: Geropharm Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials